8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 439-448

  Bianco, Caterina ^a   Tortora, Giampaolo ^a   Baldassarre, Gustavo ^a   Caputo, Rosa ^a   Fontanini, Gabriella ^b   Chine, Silvana ^b   Bianco, A Raffaele ^a   Ciardiello, Fortunato ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLOROADENOSINE 3',5' PHOSPHATE; AMPHIREGULIN; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIUM GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; TRANSFORMING GROWTH FACTOR ALPHA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030888688     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254:1146-1153, 1991.
2. Sporn, M. B.,and Roberts, A. B. Autocrine secretion: ten years later. Ann. Intern. Med.,117:408-414, 1992.
3. Salomon, D. S.,Brandt, R.,Ciardiello, F.,and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol.-Hematol.,19:183-232, 1995.
4. Saeki, T.,Stromberg, K.,Qi, C-F.,Gullick, W. J.,Tahara, E.,Normanno, N.,Ciardiello, F.,Kenney, N.,Johnson, G. R.,and Salomon, D. S. Differential immunohistochemical detection of amphiregulin and cripto in normal colon and human colorectal tumors. Cancer Res.,52: 3467-3473, 1992.
5. Panico, L.,D'Antonio, A.,Salvatore, G.,Mazza, E.,Tortora.,G.,De Laurentiis, M, De Placido, S.,Giordano, T.,Merino, M.,Salomon, D. S.,Gullick, W. J.,Pettinato, G.,Bianco, A. R.,and Ciardiello, F. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int. J. Cancer, 65:51-56, 1996.
6. Ciardiello, F.,Bianco, C.,Normanno, N.,Baldassarre, G.,Pepe, S.,Tortora, G.,Bianco, A. R.,and Salomon, D. S. Infection with a transforming growth factor α antisense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line. Int. J. Cancer, 54:952-958, 1993.
7. Ciardiello, F.,Tortora, G.,Bianco, C.,Selvam, M. P.,Basolo, F.,Fontanini, G.,Pacifico, F.,Normanno, N.,Brandt, R.,Persico, M. G.,Salomon, D. S.,and Bianco, A. R. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene, 9:291-298, 1994.
8. Normanno, N.,Bianco, C.,Damiano, V.,de Angelis, E.,Selvam, M. P.,Grassi, M.,Magliulo, G.,Tortora, G.,Bianco, A. R.,Mendelsohn, J.,Salomon, D. S.,and Ciardiello, F. Growth inhibition of human colon carcinoma cells by combinations of anti-EGF-related growth factor antisense oligonucleotides. Clin. Cancer Res.,2:601-609, 1996.
9. Kenney, N. J.,Saeki, T.,Gottardis, M.,Kim, N.,Garcia-Morales, P.,Martin, M. B.,Normanno, N.,Ciardiello, F.,Day, A.,Cutler, M. L.,and Salomon, D. S. Expression of transforming growth factor α (TGFα antisense mRNA inhibits the estrogen-induced production and the estrogen-induced proliferation of estrogen-responsive human breast cancer cells. J. Cell. Physiol.,156:497-514, 1993.
10. Folkman, J. Tumor angiogenesis. In:J. Mendelsohn, P. Howley, L. A. Liotta, and M. Israel (eds.), The Molecular Basis of Cancer, pp. 206-232. Philadelphia: W. B. Saunders, 1995.
11. Klagsbrun, M.,and D'Amore, P. A. Regulation of angiogenesis. Annu. Rev. Physiol.. 53:217-239, 1991.
12. Goldfarb, M. The fibroblast growth factor family. Cell Growth & Differ.,1: 439-445, 1990.
13. Ferrara, N.,Houck, K.,Jakeman, L.,and Leung, D. W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr. Rev.,13:18-32, 1992.
14. Maglione, D.,Guerriero, V.,Viglietto, G.,Delli-Bovi, P.,and Persico, M. G. Isolation of a human placenta cDNA for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA, 88:9267-9271, 1991.
15. Taylor, S. S.,Buechler, J. A.,and Yonemoto, W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem.,59:971-1005, 1990.
16. Cho-Chung, Y. S. Role of cAMP receptors proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res.,50: 7093-7100, 1990.
17. Tortora, G.,Pepe, S.,Cirafici, A. M.,Ciardiello, F.,Porcellini, A.,Clair, T.,Colletta, G.,Cho-Chung, Y. S.,and Bianco, A. R. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase. Cell Growth & Differ.,4:359-365, 1993.
18. Tortora, G.,Pepe, S.,Bianco, C.,Baldassarre, G.,Budillon, A.,Clair, T.,Cho-Chung, Y. S.,Bianco, A. R.,and Ciardiello, F. The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene, 9:3233-3240, 1994.
19. Rohlff, C.,Clair, T.,and Cho-Chung, Y. S. 8-Cl-cAMP induces truncation and down-regulation of the RIα subunit and up-regulation of the RIIb subunit of cAMP-dependent protein kinase leading to type holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells. J. Biol. Chem.,265: 5774-5782, 1993.
20. Tagliaferri, P.,Katsaros, D.,Clair, T.,Ally, S.,Tortora, G.,Neckers, L.,Rubalcava, B.,Parandoosh, Z.,Chang, Y. A.,Revanker, G. R.,Crabtree, G. W.,Robins, R. K.,and Cho-Chung, Y. S. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cAMP analogues. Cancer Res.,48:1642-1650, 1988.
21. Ally, S.,Clair, T.,Katsaros, D.,Tortora, G.,Yokozaki, H.,Finch, R. A.,Avery, T. L.,and Cho-Chung, Y. S. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cAMP. Cancer Res.,49:5650-5655, 1989.
22. Tortora, G.,Ciardiello, F.,Ally, S.,Clair, T.,Salomon, D. S.,and Cho-Chung, Y. S. Site-selective 8-chloro-adenosine 3′,5′ monophosphate inhibits transformation and transforming growth factor α production in Ki-ras-transformed rat fibroblasts. FEBS Lett.,242:363-367, 1989.
23. Ciardiello, F.,Tortora, G.,Kim, N.,Clair, T.,Ally, S.,Salomon, D. S.,and Cho-Chung, Y. S. 8-Cl-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J. Biol. Chem.,265: 1016-1020, 1990.
24. Ciardiello, F.,Pepe, S.,Bianco, C.,Baldassarre, G.,Ruggiero, A.,Bianco, C.,Selvam, M. P.,Bianco, A. R.,and Tortora, G. Downregulation of RIα subunit of the cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 protooncogenes. Int. J. Cancer, 53:438-443, 1993.
25. Tortora, G.,Ciardiello, F.,Pepe, S.,Tagliaferri, P.,Ruggiero, A.,Bianco, C.,Guarrasi, R.,Miki, K.,Bianco, A. R. Phase I clinical study with 8-chloro-cAMP and evaluation of immunologic effects in cancer patients. Clin. Cancer Res.,1:377-384, 1995.
26. Ciardiello, F.,Damiano, V.,Bianco, C.,di Isernia, G.,Ruggiero, A.,Caraglia, M.,Tagliaferri, P.,Baselga, J.,Mendelsohn, J.,Bianco, A. R.,and Tortora, G. Cooperative amiproliferative effects of 8-Cl-cAMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. Clin. Cancer Res.,1:161-167, 1995.
27. Ciardiello, F.,McGeady, M. L.,Kim, N.,Basolo, F.,Hynes, N.,Langton, B. C.,Yokozaki, H.,Saeki, T.,Elliott, J. W.,Masui, H.,Mendelsohn, J.,Soule, H.,Russo, J.,and Salomon, D. S. Transforming growth factor α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene and overexpression of the transforming growth factor α complementary DNA leads to transformation. Cell Growth & Differ.,1: 407-420, 1990.
28. Houck, K.,Ferrara, N.,Winer, J.,Cachianes, G.,Li, B.,and Leung, D. W. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol.,5: 1806-1814, 1991.
29. Terman, B. I.,Vermazen, D.,Carrion, M. E.,Dimitrov, D.,Armellino, D. C.,Gospodarovicz, D.,and Bohelen, P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun.,187: 1579-1586, 1992.
30. Shibuya, J.,Yamaguchi, S.,Yamane, A.,Ikeda, T.,Tojo, A.,and Sato, M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene, 8: 519-524, 1990.
31. Maglione, D.,Guerriero, V.,Rambaldi, M.,Russo, G.,and Persico M. G. Translation of the placenta growth factor mRNA is severely affected by a small open reading frame localized in the 5′ untranslated region. Growth Factors, 8:141-152, 1993.
32. Budillon, A.,Cereseto, A.,Kondrashin, A.,Nesterova, M.,Merlo, G.,Clair, T.,and Cho-Chung, Y. S. Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RIIβ regulatory subunit to lose its ability to revert transformed fibroblasts. Proc. Natl. Acad. Sci. USA, 92:10634-10638, 1995.
33. Albini, A.,Iwamoto, Y.,Kleinman, H. K.,Martin, G. R.,Aaronson, S. A.,Kozlowski, J. M.,and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res.,47:3239-3245, 1987.
34. Giunciuglio, D.,Fassina, G.,Masiello, L.,Melchiori, A.,Paglialunga, G.,Culty, M.,Arand, G.,Ciardiello, F.,Basolo, F.,Thompson, E. W.,and Albini, A. Invasive phenotype of MCF-10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int. J. Cancer, 63:815-822, 1995.
35. Baselga, J.,Norton, L.,Masui, H.,Pandiella, A.,Coplan, K.,Miller, W. H.,and Mendelsohn, J. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst.,55: 1327-1333, 1993.
36. Gitay-Goren, H.,Halobon, R.,and Neufeld, G. Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptor. Biochem. Biophys, Res. Commun.,190: 702-709, 1993.
37. Mustonen, T.,and Alitalo, K. Endothelial receptor tyrosine kinase involved in angiogenesis. J. Cell Biol.,129: 895-898, 1995.
38. Park, J. E.,Chen, H.,Winer, J.,Houck, K.,and Ferrara, N. Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk1/KDR. J. Biol. Chem.,269: 25646-25654, 1994.
39. Stetler-Stevenson, W. G.,Aznavoorian, S.,and Liotta, L. Tumor cell interactions with extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol.,9: 541-573, 1993.
40. Mensing, H.,Pontz, B. F.,Muller, P. K.,and Gauss-Muller, V. A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. Eur. J. Cell Biol.,29: 268-273, 1983.
41. Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat.,36:127-137, 1995.
42. Ferrara, N.,Winer, J.,Burton, T.,Rowland, A.,Siegel, M.,Phillips, H. S.,Terrel, T.,Keller, G. A.,and Levinson, A. D. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. Clin. Invest.,91:160-170, 1993.
43. Kim, K. J.,Li, B.,Winer, J.,Armanini, M.,Gillet, N.,Phillips, H. S.,and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362:244-250, 1993.
44. Warren, R. S.,Yuan, H.,Matli, M. R.,Gillett, N.,and Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest.,95: 1789-1797, 1995.
45. Hori, A.,Sasada, R.,and Matsutani, E. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res.,51: 6180-6184, 1991.
46. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med.,333:1757-1763, 1995.
47. Gasparini, G.,and Harris, A. L. Clinical implications of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol.,13:765-782, 1995.
48. Mendelsohn, J. Potential clinical applications of anti-EGF receptor monoclonal antibodies. Cancer Cells, 7:359-362, 1989.
49. Baselga, J.,and Mendelsohn, J. The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res. Treat.,29: 127-138, 1994.